Clinical Trial Update: Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ARO-ATXN2 Injection for Spinocerebellar Ataxia Type 2 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia Type

Drugs mentioned

• ARO-ATXN2 (ARO-ATXN2)

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Spinocerebellar Ataxia Type 2 | Phase 1 | Status: RECRUITING